Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.
Also called NCT01362218
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 107 participants
- Sponsor
- Registry
-
NCT01362218
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Terminated
Technical summary
Registry record NCT01362218. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
- Condition
- Elevated LDL Cholesterol
- Intervention (Drug)
- Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)
- Intervention (Drug)
- Simvastatin, ramipril, acetylsalicylic acid
- Lead sponsor
- Ferrer Internacional S.A.
Record details
- Record id
cardio:ct-nct01362218- Content hash
fded7437983e9cb24c67a820fe4f2c745065cf0058c09896f50b20052ef17519